RecruitingNot ApplicableNCT06528626

Tools to Identify People At Risk or Already Infected with HIV and HCV

Wedge-Shaped Clusterded Randomizad Trial to Evaluate Two Tools to Identify People At Risk or Already Infected with HIV and HCV

Sponsor

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Enrollment

240,000 participants

Start Date

Jul 1, 2023

Study Type

INTERVENTIONAL

Conditions

HCV HIV/AIDS STD

Summary

Wedge-Shaped Clusterded Randomizad Trial to Evaluate Two Tools to identify People at Risk or already Infected with HIV and HCV

Eligibility

Min Age: 14 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing new tools to help identify people who are at risk of HIV or hepatitis C (HCV) infection, or who may already be infected, so they can get help sooner. You may be eligible if: you are between 14 and 65 years old and live in the study area, or are identified by a health worker for inclusion; and you are willing to give your consent to participate. You may NOT be eligible if: you have already been included in this study; or you are not willing to sign the consent form. Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTrapid HIV and HCV serological tests

In the standard of care branch (SOC), the health personnel will ask people a series of questions to identify the HIV risk exposition, and also they will be provided pop-up computer alerts of HIV indicator conditions in the electronic medical record, moreover HIV and HCV serological tests will be carried out in the reference laboratory, while in the intervention branch in addition to the SOC, a SQ-R\&IC of HIV and HCV will be made available to the HC population, through a quick response (QR) code, as well as HIV and HCV RT.

Locations(1)

Maria J. Vivancos-Gallego

Madrid, Madrid, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06528626

Related Trials

An Economic and Relationship-strengthening Intervention to Reduce Alcohol Use in Malawi

NCT063673481 location

PrEP My Way: A Hybrid Type 1 Clinical Effectiveness-implementation Trial to Promote PrEP Persistence Among Young Kenyan Women

NCT065664301 location